- Home
- LPTH vs QURE Comparison
LPTH vs QURE Comparison
Compare LPTH & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LPTH | QURE |
|---|---|---|
| Founded | 1985 | 1998 |
| Country | United States | Netherlands |
| Employees | N/A | 248 |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.1B |
| IPO Year | 2011 | 2013 |
Fundamental Metrics
Financial Performance| Metric | LPTH | QURE |
|---|---|---|
| Price | $15.89 | $45.17 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 14 |
| Target Price | $13.33 | ★ $45.00 |
| AVG Volume (30 Days) | ★ 3.8M | 2.8M |
| Earning Date | 05-14-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 29.67 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $37,202,630.00 | $13,107,000.00 |
| Revenue This Year | $83.04 | $126.12 |
| Revenue Next Year | $24.83 | $200.43 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 17.26 | N/A |
| 52 Week Low | $2.75 | $8.73 |
| 52 Week High | $18.94 | $71.50 |
Technical Indicators
Market Signals| Indicator | LPTH | QURE |
|---|---|---|
| Relative Strength Index (RSI) | 55.40 | 67.91 |
| Support Level | $10.06 | $22.20 |
| Resistance Level | $18.94 | $60.70 |
| Average True Range (ATR) | 1.33 | 3.02 |
| MACD | 0.06 | 0.60 |
| Stochastic Oscillator | 81.73 | 79.72 |
Price Performance
Historical ComparisonAbout LPTH LightPath Technologies Inc.
LightPath Technologies Inc manufactures, distributes, and integrates proprietary optical components and assemblies. It develops optical solutions for traditional optics and communications markets. The company's products include precision molded optics and infrared products, serving markets such as distribution, laser, industrial, instrumentation, telecommunications, and defense. Its products are categorized as infrared components, visible components, assemblies and modules, and engineering services. G5 Infrared's revenue mainly comes from infrared components and assemblies.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.